Antithrombin and hypercoagulability in sepsis: insights from thrombelastography?

Episode von Medizin - Open Access LMU - Teil 15/22 von Ludwig-Maximilians-Universität München · 1. Januar 2007

Antithrombin (AT) has been used for over 25 years to successfully treat disseminated intravascular coagulation (DIC). A four-day AT therapy in patients with DIC in the KyberSept trial has been related to a clear survival benefit in patients not receiving concomitant heparin. Gonano and coworkers performed thrombelastography (TEG) measurements in patients with severe sepsis and clearly showed hypercoagulability, as defined by five TEG parameters, compared to healthy controls. In the AT group they found a trend towards normalization of TEG parameters after treatment, although this did not reach statistical significance. This first clinical evaluation of hypercoagulability during AT treatment could not provide evidence for an attenuation of coagulopathy, an effect that might be due to high inter-individual variability.

Weitere Episoden von „Medizin - Open Access LMU - Teil 15/22“

Über den Podcast

Die Universitätsbibliothek (UB) verfügt über ein umfangreiches Archiv an elektronischen Medien, das von Volltextsammlungen über Zeitungsarchive, Wörterbücher und Enzyklopädien bis hin zu ausführlichen Bibliographien und mehr als 1000 Datenbanken reicht. Auf iTunes U stellt die UB unter anderem…

Medizin - Open Access LMU - Teil 15/22

Ähnliche Episoden

Alle Episoden von Medizin - Open Access LMU - Teil 15/22 · Mehr Bildung-Podcasts